Tarsus Pharmaceuticals Inc Sustainability Reports
Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for eye care, starting with its FDA-approved treatment for Demodex blepharitis. It also develops pipelines targeting other ophthalmic conditions and infectious disease prevention.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00RB9BNR6
2 reports from 2021 to 2022